Cystic fibrosis discovery

Scientists have developed a formulation that increases the delivery of a novel “antivirulence” agent to the lungs to manage cystic fibrosis A new rat study presented at the International Pharmaceutical Federation’s Pharmaceutical Sciences World Congress means health stakeholders are a step closer to better treatment for the condition, say researchers. About 80% of cystic fibrosis